These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 18589650

  • 1. [Role of impaired immune response regulatory processes in the pathogenesis of uveitis associated with rheumatic diseases].
    Drozdova EA, Teplova SN.
    Vestn Oftalmol; 2008; 124(3):23-6. PubMed ID: 18589650
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Distribution of HLA class I antigens in patients with uveitis in the presence of rheumatic diseases].
    Drozdova EA.
    Vestn Oftalmol; 2006; 122(2):3-6. PubMed ID: 16886739
    [Abstract] [Full Text] [Related]

  • 6. Immunological aspects of viral uveitis.
    Martenet AC.
    Mod Probl Ophthalmol; 1976; 16():215-9. PubMed ID: 765784
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The value of neopterin in etiological diagnosis of endogenous uveitis].
    Onishchenko AL, Kolbasko AV, Chernysheva AD, Surzhikova GS.
    Vestn Oftalmol; 2011; 127(2):25-9. PubMed ID: 21721268
    [Abstract] [Full Text] [Related]

  • 9. [Immunologic peculiarities of uveitis concurrent with systemic pathologies].
    Drozdova EA, Tarasova LN, Teplova SN, Alekhina TV.
    Vestn Oftalmol; 2004; 120(4):24-6. PubMed ID: 15384843
    [Abstract] [Full Text] [Related]

  • 10. [Outcomes of uveitis in systemic and syndromic diseases and their relation to the immunological status of the patient].
    Zaĭtseva NS, Katsnel'son LA, Rysaeva AG, Murav'eva TV, Slepova OS.
    Oftalmol Zh; 1982; 37(8):494-9. PubMed ID: 6984498
    [No Abstract] [Full Text] [Related]

  • 11. Harms and benefits of lymphocyte subpopulations in patients with acute stroke.
    Urra X, Cervera A, Villamor N, Planas AM, Chamorro A.
    Neuroscience; 2009 Feb 06; 158(3):1174-83. PubMed ID: 18619524
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Peripheral immune response in pulmonary tuberculosis.
    Aktas E, Ciftci F, Bilgic S, Sezer O, Bozkanat E, Deniz O, Citici U, Deniz G.
    Scand J Immunol; 2009 Sep 06; 70(3):300-8. PubMed ID: 19703020
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Significance and the course of cell-mediated response in uveitis].
    Rusiecka-Ziółkowska J.
    Przegl Lek; 2002 Sep 06; 59(2):113-4. PubMed ID: 12152247
    [Abstract] [Full Text] [Related]

  • 18. [Hyper-IGE reactions in uveitis and their immunomodulation with cytokine-containing agents].
    Teplinskaia LE, Filichkina NS.
    Vestn Oftalmol; 2006 Sep 06; 122(6):33-5. PubMed ID: 17217200
    [Abstract] [Full Text] [Related]

  • 19. Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis e.
    Saravanabalaji S, Tripathy AS, Dhoot RR, Chadha MS, Kakrani AL, Arankalle VA.
    Intervirology; 2009 Sep 06; 52(2):78-85. PubMed ID: 19401616
    [Abstract] [Full Text] [Related]

  • 20. Immunostimulatory properties and enhanced TNF- alpha mediated cellular immunity for tumor therapy by C60(OH)20 nanoparticles.
    Liu Y, Jiao F, Qiu Y, Li W, Qu Y, Tian C, Li Y, Bai R, Lao F, Zhao Y, Chai Z, Chen C.
    Nanotechnology; 2009 Oct 14; 20(41):415102. PubMed ID: 19755733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.